What is the 13F Pro Quality Score for CI?

13F Pro ranks Cigna Group (CI) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View CI's current score at https://13fpro.ai/company/CI (free sign-up required for the full ranking).

Which hedge funds own the most CI stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of CI include BlackRock,, VANGUARD CAPITAL MANAGEMENT, STATE STREET. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/company/CI as soon as new 13F filings post.

Where does 13F Pro source CI data?

All Cigna Group fundamentals and ownership data come directly from SEC EDGAR. Cigna Group files with the SEC under CIK 1739940. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is CI in?

Cigna Group (CI) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

What drives CI's revenue?

Per Cigna Group's latest 10-Q filed with the SEC on 2026-07-30, the biggest revenue drivers are: Evernorth Health Services ($61.5B, +6% YoY); Cigna Healthcare ($11.8B, +9% YoY); Pharmacy Benefit Services ($34.5B, +8% YoY). Figures are extracted from the filing text and machine-verified against the document. Full breakdown at https://13fpro.ai/company/CI.

What are CI's largest expenses?

Cigna Group's latest 10-Q reports these as the largest expense items: Pharmacy and other service costs ($56.7B, +6% YoY); Medical costs and other benefit expenses ($8.4B, +9% YoY); Selling, general and administrative expenses ($3.5B, +1% YoY). Sourced directly from SEC EDGAR filing text for Q2 2026 (quarter ended June 30, 2026).

How often is CI research updated on 13F Pro?

CI's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

Cigna Group(CI)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →NYSElarge

Institutional-grade research for retail investors

SEC EDGAR: CIK 1739940 CI stock profile & AI dashboard →

13F Pro Quality Score

66.2/100

Rank #438 of 2,960 stocksTOP 25%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

70.1/100

Profitability

42.0/100

Balance Sheet

66.3/100

Earnings Quality

75.8/100

Free Cash Flow

37.6/100

Institutional Flow

59.1/100

Revenue Scale

99.5/100

Dilution Risk

87.9/100

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why CI Scores 66/100

exact factor attribution · 2026-09-10

CI's composite is driven by scale and revenue growth, held back by free cash flow and profitability. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Scale

+7.4 pts

100th pct

Revenue growth

+4.0 pts

70th pct

Earnings quality

+2.6 pts

76th pct

Shareholder dilution

+1.9 pts

88th pct

Capital efficiency

+1.6 pts

66th pct

Earnings growth

+1.2 pts

75th pct

Institutional flow

+0.5 pts

59th pct

Profitability

-1.2 pts

42th pct

Free cash flow

-1.9 pts

38th pct

Latest change (2026-08-01): 67 → 61 · ↓ Revenue growth 76→57; ↓ Earnings growth 75→65

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

CI Stock Analysis & AI Quality Score

Data updated 2026-09-10

AI stock analysis and institutional research for Cigna Group (CI), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores CI at 66.2/100 on a 32-signal composite quality model, placing it at rank #438 of 2,960 stocks — the top 25% of the AI-ranked universe. CI scores in the top quartile across revenue scale (99.5), earnings quality (75.8). Areas of concern include free cash flow (37.6), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), Cigna Group reports quarterly revenue of $71.7B, net income of $1.7B, an operating margin of 3.7%. Top institutional holders of CI by reported 13-F value include BlackRock, VANGUARD CAPITAL MANAGEMENT, STATE STREET, based on the most recent SEC filings. CI trades on the NYSE exchange and files with the SEC under CIK 1739940. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Cigna Group directly from SEC EDGAR. Cigna Group's 13F Pro composite quality score has ranged between 52 and 68 since 2021, currently 66.2 — a stable long-term trajectory across 68 quarterly and live scoring snapshots.

What's Driving CI's Business? Latest 10-Q Breakdown

✓ 26/26 datapoints verified

AI-extracted from Cigna Group's 10-Q filed 2026-07-30 — Q2 2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

Total revenues rose 7% to $71.7B on pharmacy claims composition and higher Cigna Healthcare premium rates, lifting shareholders' net income 8% to $1.66B.

Biggest Revenue Drivers

Evernorth Health Services$61.5B+6% YoY

Increase due to claims composition in Pharmacy Benefit Services and higher claims volume from customer growth in Specialty and Care Services

Cigna Healthcare$11.8B+9% YoY

Higher premiums (+$664 million), mostly within employer insured and stop loss, primarily reflecting premium rate increases

Biggest Revenue Drivers

Total revenue: $71.7B+7% YoY

Evernorth Health Services$61.5B+6% YoY

Increase due to claims composition in Pharmacy Benefit Services and higher claims volume from customer growth in Specialty and Care Services

Within Evernorth Health Services

Pharmacy Benefit Services$34.5B+8% YoY

Claims composition, partially offset by lower claims volume (-2%)

Specialty and Care Services$27.0B+4% YoY

Customer and client growth in specialty pharmacy and care services

Cigna Healthcare$11.8B+9% YoY

Higher premiums (+$664 million), mostly within employer insured and stop loss, primarily reflecting premium rate increases

Other Operations$131M-29% YoY

Primarily driven by the discontinuation of certain small non-strategic businesses

Largest Expense Items

Pharmacy and other service costs$56.7B+6% YoY

Primarily reflecting changes in claims composition within Pharmacy Benefit Services

Medical costs and other benefit expenses$8.4B+9% YoY

Primarily reflecting higher medical costs within Cigna Healthcare

Selling, general and administrative expenses$3.5B+1% YoY

Includes $69 million pre-tax strategic optimization costs and $77 million of litigation charges

Amortization of acquired intangible assets$389M-8% YoY

Margins: Cigna Healthcare pre-tax margin rose 70 bps to 10.9%, though its medical care ratio worsened 130 bps to 84.5% on prior-year risk adjustment benefits in 2025; Evernorth pre-tax margin slipped 20 bps to 2.7%.

Watch Items from the Filing

Pharmacy Benefit Services pre-tax adjusted income fell 27% to $609 million on client- and customer-focused initiatives (-11%) and lower claims volume; pharmacy claim volume declined 2% to 537 million.
The Company announced in April 2026 a planned exit from the Individual and Family Plans medical business as of January 1, 2027; segment premiums were $860 million in the quarter.
Strategic optimization program cost $70 million pre-tax in the quarter and $1,199 million program-to-date, running through 2028, with $269 million accrued liability outstanding.
Reinsurance concentration: $3,054 million of recoverables from six reinsurers rated BBB+ or higher, 77% held by two Lincoln entities; Berkshire limit has ~$3.0 billion remaining.
Litigation charges of $77 million pre-tax were recorded in the quarter within Cigna Healthcare; accounts receivable allowances rose to $7.4 billion from $6.8 billion.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Read the full 10-Q on SEC EDGAR →Share on X

Revenue

Q2 2026

$71.7B

Net Income

Q2 2026

$1.7B

Operating Margin

Q2 2026

3.7%

ROIC

Q2 2026

14.4%

D/E Ratio

Q2 2026

0.75

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+11.2% YoY

$274.90BFY 2025

FY22 $180.52BFY23 $195.26BFY24 $247.12BFY25 $274.90B

Net Income

+73.5% YoY

$5.96BFY 2025

FY22 —FY23 $5.16BFY24 $3.43BFY25 $5.96B

Operating Income

-2.3% YoY

$9.20BFY 2025

FY22 $8.45BFY23 $8.54BFY24 $9.42BFY25 $9.20B

EPS (Diluted)

+83.0% YoY

$22.18FY 2025

FY22 $21.41FY23 $17.39FY24 $12.12FY25 $22.18

Total Assets

+1.3% YoY

$157.92BFY 2025

FY22 $143.88BFY23 $152.76BFY24 $155.88BFY25 $157.92B

Total Debt

-1.6% YoY

$31.46BFY 2025

FY22 $31.09BFY23 $30.93BFY24 $31.97BFY25 $31.46B

Op. Cash Flow

-7.4% YoY

$9.60BFY 2025

FY22 $8.66BFY23 $11.81BFY24 $10.36BFY25 $9.60B

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$274.90B +11.2%	$247.12B +26.6%	$195.26B +8.2%	$180.52B +3.7%	$174.07B +8.5%	$160.40B
Net Income	$5.96B +73.5%	$3.43B -33.5%	$5.16B	—	—	—
Operating Income	$9.20B -2.3%	$9.42B +10.3%	$8.54B +1.0%	$8.45B +6.4%	$7.94B -2.6%	$8.15B
EPS (Diluted)	$22.18 +83.0%	$12.12 -30.3%	$17.39 -18.8%	$21.41 +35.9%	$15.75 -31.4%	$22.96
Total Assets	$157.92B +1.3%	$155.88B +2.0%	$152.76B +6.2%	$143.88B -7.1%	$154.89B -0.4%	$155.45B
Total Debt	$31.46B -1.6%	$31.97B +3.4%	$30.93B -0.5%	$31.09B -7.7%	$33.67B +2.3%	$32.92B
Operating Cash Flow	$9.60B -7.4%	$10.36B -12.3%	$11.81B +36.5%	$8.66B +20.4%	$7.19B -30.5%	$10.35B

Get alerted when CI's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Cigna Group including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of CI

BlackRock, Inc.
$6.5B23,438,250 sh
VANGUARD CAPITAL MANAGEMENT LLC
$4.8B17,276,296 sh
STATE STREET CORP
$3.5B12,682,259 sh
DODGE & COX
$3.4B12,173,875 sh
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
$2.9B10,443,691 sh
Sanders Capital, LLC
$2.8B10,144,617 sh
FMR LLC
$2.2B8,018,189 sh
GEODE CAPITAL MANAGEMENT, LLC
$1.7B6,268,347 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$1.7B6,228,614 sh
GQG Partners LLC
$1.6B5,908,707 sh

Fund	Value	Shares
BlackRock, Inc.	$6.5B	23,438,250
VANGUARD CAPITAL MANAGEMENT LLC	$4.8B	17,276,296
STATE STREET CORP	$3.5B	12,682,259
DODGE & COX	$3.4B	12,173,875
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	$2.9B	10,443,691
Sanders Capital, LLC	$2.8B	10,144,617
FMR LLC	$2.2B	8,018,189
GEODE CAPITAL MANAGEMENT, LLC	$1.7B	6,268,347
VANGUARD PORTFOLIO MANAGEMENT LLC	$1.7B	6,228,614
GQG Partners LLC	$1.6B	5,908,707

Companies Similar to CI

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

MMM

3M CO

AI score

Very similar · 32 shared holders

Capital World Investors National Pension Service Boston Partners

BMY

BRISTOL MYERS SQUIBB CO

AI score

Very similar · 43 shared holders

NORDEA INVESTMENT MANAGEMENT AB National Pension Service CAISSE DE DEPOT ET PLACEMENT DU QUEBEC

CVS

CVS HEALTH Corp

AI score

Very similar · 47 shared holders

DODGE & COX GQG Partners LLC DAVIS SELECTED ADVISERS

MDT

Medtronic plc

AI score

Very similar · 35 shared holders

DODGE & COX HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC Capital World Investors

AMGN

AMGEN INC

AI score

Very similar · 38 shared holders

NORDEA INVESTMENT MANAGEMENT AB Capital World Investors Capital Research Global Investors

ABT

ABBOTT LABORATORIES

AI score

Very similar · 35 shared holders

Grantham, Mayo, Van Otterloo & Co. LLC Capital Research Global Investors National Pension Service

ZTS

Zoetis Inc.

AI score

Very similar · 24 shared holders

NORDEA INVESTMENT MANAGEMENT AB BRANDES INVESTMENT PARTNERS, LP WORLDQUANT MILLENNIUM ADVISORS LLC

HCA

HCA Healthcare, Inc.

AI score

Very similar · 39 shared holders

Sanders Capital, LLC NORDEA INVESTMENT MANAGEMENT AB Capital World Investors

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put CI on your watchlist

Track score changes the day Cigna Group files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is CI a good stock to buy?

13F Pro's AI-powered analysis of Cigna Group (CI) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CI are available on the CI stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. CI is classified as a large company.

Which hedge funds own CI?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CI. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Cigna Group's investment landscape.